Literature DB >> 10975862

Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium.

C D Buckley1, N Amft, P F Bradfield, D Pilling, E Ross, F Arenzana-Seisdedos, A Amara, S J Curnow, J M Lord, D Scheel-Toellner, M Salmon.   

Abstract

Chemokines and their receptors determine the distribution of leukocytes within tissues in health and disease. We have studied the role of the constitutive chemokine receptor CXCR4 and its ligand, stromal-derived factor-1 (SDF-1) in the perivascular accumulation of T cells in rheumatoid arthritis. We show that synovial T cells, which are primed CD45RO+CD45RBdull cells and consequently not expected to express constitutive chemokine receptors, have high levels of the chemokine receptor CXCR4. Sustained expression of CXCR4 was maintained on synovial T cells by specific factors present within the synovial microenvironment. Extensive screening revealed that TGF-beta isoforms induce the expression of CXCR4 on CD4 T cells in vitro. Depletion studies using synovial fluid confirmed an important role for TGF-beta1 in the induction of CXCR4 expression in vivo. The only known ligand for CXCR4 is SDF-1. We found SDF-1 on synovial endothelial cells and showed that SDF-1 was able to induce strong integrin-mediated adhesion of synovial fluid T cells to fibronectin and ICAM-1, confirming that CXCR4 expressed on synovial T cells was functional. These results suggest that the persistent induction of CXCR4 on synovial T cells by TGF-beta1 leads to their active, SDF-1-mediated retention in a perivascular distribution within the rheumatoid synovium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975862     DOI: 10.4049/jimmunol.165.6.3423

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  98 in total

1.  Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases.

Authors:  H Brühl; K Wagner; H Kellner; M Schattenkirchner; D Schlöndorff; M Mack
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  Inhibition of fibrocyte differentiation by serum amyloid P.

Authors:  Darrell Pilling; Christopher D Buckley; Mike Salmon; Richard H Gomer
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

Review 3.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

4.  The role of chemokines and extracellular matrix components in the migration of T lymphocytes into three-dimensional substrata.

Authors:  Jyrki Ivanoff; Toomas Talme; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

Review 5.  Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology.

Authors:  Meizhang Li; Richard M Ransohoff
Journal:  Prog Neurobiol       Date:  2007-11-26       Impact factor: 11.685

6.  Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist.

Authors:  Stephen Jenkinson; Michael Thomson; David McCoy; Mark Edelstein; Susan Danehower; Wendell Lawrence; Pat Wheelan; Andrew Spaltenstein; Kristjan Gudmundsson
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

7.  AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formation.

Authors:  Jerry S Hu; Christine M Freeman; Valerie R Stolberg; Bo Chin Chiu; Gary J Bridger; Simon P Fricker; Nicholas W Lukacs; Stephen W Chensue
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 8.  Physiology and pharmacology of plerixafor.

Authors:  Simon P Fricker
Journal:  Transfus Med Hemother       Date:  2013-07-19       Impact factor: 3.747

Review 9.  Chemokines in joint disease: the key to inflammation?

Authors:  J J Haringman; J Ludikhuize; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

Review 10.  The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis.

Authors:  Andrew Filer; Karim Raza; Mike Salmon; Christopher D Buckley
Journal:  Front Biosci       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.